Related Experiment Video
Updated: Sep 10, 2025

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
The Non-Traditional Cardiovascular Culprits in Chronic Kidney Disease: Mineral Imbalance and Uremic Toxin
Yue Lu1, Linlin Meng1, Xinlu Wang1
1State Key Laboratory for Innovation and Transformation of Luobing Theory, Key Laboratory of Cardiovascular Remodeling and Function Research of MOE, NHC, CAMS and Shandong Province, Department of Cardiology, Qilu Hospital of Shandong University, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.
Insights
Chronic kidney disease (CKD) elevates mortality risk through cardiovascular disease (CVD). Metabolic imbalances and uremic toxins in CKD drive CVD progression and organ damage, necessitating novel therapeutic strategies.
Area of Science:
- Nephrology
- Cardiology
- Metabolic Medicine
Background:
- Chronic kidney disease (CKD) significantly increases mortality, mainly from cardiovascular disease (CVD).
- Traditional cardiovascular risk factors do not fully explain this elevated risk, pointing to non-traditional factors in CKD.
- CKD disrupts mineral balance and leads to uremic toxin accumulation, stressing the cardiovascular system and worsening kidney function.
Purpose of the Study:
- To elucidate the pathophysiological links between CKD and CVD.
- To focus on metabolic regulatory mechanisms involving minerals (calcium, phosphate) and uremic toxins.
- To review how these factors contribute to multi-organ damage and discuss therapeutic strategies.
Main Methods:
- Literature review focusing on the interplay between CKD and CVD.
- Analysis of metabolic dysregulation, mineral imbalance, and uremic toxin effects.
- Examination of mechanisms including inflammation, endothelial dysfunction, oxidative stress, and vascular calcification.
Main Results:
- CKD-associated metabolic abnormalities and uremic toxins accelerate cardiovascular damage.
- These factors promote inflammation, endothelial dysfunction, oxidative stress, and vascular calcification.
- The relationship between CKD and CVD is bidirectional, with each condition exacerbating the other.
Conclusions:
- Metabolic dysregulation in CKD is a key driver of cardiovascular complications.
- Targeting uremic toxins and mineral imbalances offers potential therapeutic avenues.
- Further research is needed to develop innovative treatments for improving outcomes in CKD-CVD patients.
Abstract:
Chronic kidney disease (CKD) is associated with a significantly elevated mortality rate, primarily due to cardiovascular disease (CVD), highlighting a complex bidirectional relationship between the two conditions. Life-threatening cardiovascular events occur despite control of the traditional risk factors, emphasizing the underlying role of non-traditional risk factors. CKD, causing mineral imbalance and the accumulation of uremic toxins due to a compromised ability to excrete waste products, imposes extra pressure on the cardiovascular system. The retention of mineral and uremic toxins, in turn, aggravates the progression of CKD. This review aims to elucidate the pathophysiological connections between CKD and CVD, with a particular focus on the metabolic regulatory mechanisms influenced by minerals such as calcium and phosphate, as well as uremic toxins. We review how these factors contributed to accelerated multi-organ damage through mechanisms such as inflammation, endothelial dysfunction, oxidative stress, and vascular calcification. In addition, we discuss the therapeutic strategies for specific uremic toxins and proposed directions for future investigations. This review provides insights into the complex interplay between metabolic dysregulation and cardiovascular outcomes in CKD patients, promoting the development of innovative therapeutic interventions, ultimately improving the prognosis and quality of life for patients affected by these interconnected conditions.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Heart Failure Drugs: Diuretics
Acute Kidney Injury IV: Diagnostic Studies and Prevention

